Using the same model in mice, we found that genetic ablation of MIF combined with dexamethasone treatment just prior to the acute phase of EAM reduced disease severity and prevented progression to DCM (unpublished data). This evidence concerns the gene MIF and familial dilated cardiomyopathy.